AVITA MEDICAL INC (RCEL) Forecast, Price Target & Analyst Ratings

NASDAQ:RCEL • US05380C1027

Current stock price

5.6 USD
+0.69 (+14.05%)
At close:
5.7398 USD
+0.14 (+2.5%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AVITA MEDICAL INC (RCEL).

Forecast Snapshot

Consensus Price Target

Price Target
$6.53
+ 16.57% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.29
Revenue Estimate
18.539M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.53
Upside
+ 16.57%
From current price of $5.60 to mean target of $6.53, Based on 12 analyst forecasts
Low
$3.03
Median
$5.61
High
$10.50

Price Target Revisions

1 Month
3.23%
3 Months
-7.25%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for RCEL. The average price target is 6.53 USD. This implies a price increase of 16.57% is expected in the next year compared to the current price of 5.6.
The average price target has been revised downward by 7.25% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RCEL Current Analyst RatingRCEL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

RCEL Historical Analyst RatingsRCEL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
RCEL was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about RCEL.
In the previous month the buy percentage consensus was at a similar level.
RCEL was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-09D. Boral CapitalMaintains Buy -> Buy
2026-04-08D. Boral CapitalMaintains Buy -> Buy
2026-03-05Northland Capital MarketsInitiate Outperform
2026-02-17D. Boral CapitalMaintains Buy -> Buy
2026-01-26D. Boral CapitalMaintains Buy -> Buy
2026-01-16Lake StreetMaintains Hold -> Hold
2026-01-15D. Boral CapitalMaintains Buy -> Buy
2025-11-20BTIGUpgrade Sell -> Neutral
2025-11-07D. Boral CapitalMaintains Buy -> Buy
2025-10-17D. Boral CapitalMaintains Buy -> Buy
2025-10-17Lake StreetDowngrade Buy -> Hold
2025-09-15D. Boral CapitalMaintains Buy -> Buy
2025-09-05D. Boral CapitalMaintains Buy -> Buy
2025-08-11Lake StreetMaintains Buy -> Buy
2025-08-08D. Boral CapitalMaintains Buy -> Buy
2025-06-10D. Boral CapitalMaintains Buy -> Buy
2025-06-06D. Boral CapitalMaintains Buy -> Buy
2025-04-10D. Boral CapitalMaintains Buy -> Buy
2025-04-04D. Boral CapitalMaintains Buy -> Buy
2025-03-18D. Boral CapitalMaintains Buy -> Buy
2025-02-20D. Boral CapitalMaintains Buy -> Buy
2025-02-14D. Boral CapitalMaintains Buy -> Buy
2025-01-08D. Boral CapitalMaintains Buy -> Buy
2025-01-08Lake StreetMaintains Buy -> Buy
2024-12-24D. Boral CapitalInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.29
Revenue Estimate
18.539M
Revenue Q2Q
0.14%
EPS Q2Q
46.11%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-6.47%
EPS (1 Month)
0.00%
EPS (3 Months)
4.54%

Next Earnings Summary

RCEL is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.29 USD and the consensus revenue estimate is 18.54M USD.
The next earnings revenue estimate has been revised downward by 6.47% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RCEL revenue by date.RCEL revenue by date.
50.143M
45.68%		64.251M
28.14%		71.61M
11.45%		83.903M
17.17%		125.7M
49.82%		232.57M
85.02%		290.18M
24.77%		339.92M
17.14%		405.89M
19.41%		481.45M
18.62%		590.61M
22.67%
EBITDA
YoY % growth
RCEL ebitda by date.RCEL ebitda by date.
-41.715M
-57.06%		-54.873M
-31.54%		-38.777M
29.33%		-19.312M
50.20%		-12.036M
37.68%		20.4M
269.49%		38.078M
86.66%		44.714M
17.43%		50.839M
13.70%		56.862M
11.85%		62.783M
10.41%
EBIT
YoY % growth
RCEL ebit by date.RCEL ebit by date.
-42.347M
-56.09%		-55.999M
-32.24%		-41.124M
26.56%		-30.874M
24.92%		7.676M
124.86%		94.511M
1,131.25%		101.29M
7.17%		139.94M
38.16%		188.48M
34.69%		234.41M
24.37%		418.42M
78.50%
Operating Margin
RCEL operating margin by date.RCEL operating margin by date.
-84.45%-87.16%-57.43%-36.80%6.11%40.64%34.91%41.17%46.44%48.69%70.85%
EPS
YoY % growth
RCEL eps by date.RCEL eps by date.
-1.40
-30.84%		-2.39
-70.71%		-1.75
26.78%		-0.88
49.97%		-0.75
14.25%		1.17
255.57%		2.82
141.45%		3.70
31.15%		4.84
30.92%		6.11
26.17%		7.89
29.09%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.29
46.11%		-0.26
31.55%		-0.22
52.88%		-0.19
51.01%		-0.18
35.71%		-0.16
37.25%		-0.09
57.65%		-0.10
45.21%
Revenue
Q2Q % growth		18.539M
0.14%		20.296M
10.20%		21.295M
24.81%		23.582M
33.87%		23.46M
26.54%		24.837M
22.37%		25.092M
17.83%		28.509M
20.89%
EBITDA
Q2Q % growth		-5.304M
51.75%		-4.845M
50.79%		-4.08M
44.52%		-3.264M
55.57%		-5.508M
-3.85%		-5.1M
-5.26%		-2.856M
30.00%		2.346M
171.88%
EBIT
Q2Q % growth		-9.835M
14.58%		-7.932M
27.35%		-7.072M
21.43%		-6.045M
37.64%		-5.508M
44.00%		-5.1M
35.70%		-2.856M
59.62%		-3.06M
49.38%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RCEL Yearly Revenue VS EstimatesRCEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
RCEL Yearly EPS VS EstimatesRCEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
38.68%
EPS Next 5 Year
32.69%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
47.36%
Revenue Next 5 Year
36.14%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
35.15%
EBIT Next 5 Year
24.79%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AVITA MEDICAL INC / RCEL Forecast FAQ

What is the price target for RCEL stock?

12 analysts have analysed RCEL and the average price target is 6.53 USD. This implies a price increase of 16.57% is expected in the next year compared to the current price of 5.6.

When does AVITA MEDICAL INC (RCEL) report earnings?

AVITA MEDICAL INC (RCEL) will report earnings on 2026-05-07.

What are the consensus estimates for RCEL stock next earnings?

The consensus EPS estimate for the next earnings of AVITA MEDICAL INC (RCEL) is -0.29 USD and the consensus revenue estimate is 18.54M USD.

How do analysts rate AVITA MEDICAL INC (RCEL)?

The consensus rating for AVITA MEDICAL INC (RCEL) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.